#1 Clinical Trials Search in Europe

Fluocinolone Acetonide

Fluocinolone Acetonide is a corticosteroid medication being studied in various clinical trials for treating eye conditions. These trials are exploring its effectiveness when administered as intravitreal implants or inserts for conditions like uveitis, diabetic macular edema, and retinal vein occlusion. The research aims to evaluate the safety and efficacy of different doses and delivery methods of Fluocinolone Acetonide in managing inflammation and improving vision in patients with these eye disorders.

Table of Contents

What is Fluocinolone Acetonide?

Fluocinolone Acetonide is a powerful corticosteroid medication used to treat various eye conditions. It works by reducing inflammation in the eye, which is a common factor in many eye diseases[1]. This medication is particularly useful for conditions that affect the back part of the eye, known as the posterior segment[2].

Conditions Treated with Fluocinolone Acetonide

Fluocinolone Acetonide is used to treat several eye conditions, including:

  • Diabetic Macular Edema (DME): A condition where fluid builds up in the macula (central part of the retina) due to diabetes, causing vision problems[3][4].
  • Non-infectious Uveitis: Inflammation of the middle layer of the eye not caused by infection[1][5].
  • Retinal Vein Occlusion (RVO): A condition where the veins in the retina become blocked, leading to vision loss[6].
  • Age-Related Macular Degeneration (AMD): A condition that affects the macula, causing vision loss in older adults[7][8].
  • Radiation Retinopathy: Damage to the retina caused by radiation therapy[9].

Administration Methods

Fluocinolone Acetonide is typically administered in two main ways:

  1. Intravitreal Implant: A tiny device containing the medication is surgically placed inside the eye. This method provides long-term, sustained release of the medication[1][2].
  2. Intravitreal Injection: The medication is directly injected into the eye. This method may require more frequent treatments compared to the implant[6].

Dosage Forms

Fluocinolone Acetonide is available in different dosage forms and strengths, including:

  • 0.19 mg implant (known as Iluvien)[9]
  • 0.59 mg implant[1]
  • 2.1 mg implant[1]
  • 0.2 μg/day release rate[6]
  • 0.5 μg/day release rate[6]

The choice of dosage form and strength depends on the specific condition being treated and the patient’s individual needs.

Efficacy and Benefits

Fluocinolone Acetonide has shown several benefits in clinical trials:

  • Improved vision or prevention of vision loss in various eye conditions[6][1].
  • Reduction in the frequency of uveitis recurrences[1].
  • Decreased need for additional treatments or medications[1].
  • Long-term control of inflammation, potentially lasting up to 3 years with a single implant[1].
  • Potential to reduce the number of injections needed in conditions like Age-Related Macular Degeneration[8].

Potential Side Effects

While Fluocinolone Acetonide can be effective, it’s important to be aware of potential side effects:

  • Increased Intraocular Pressure (IOP): This is pressure inside the eye, which can potentially lead to glaucoma if not managed[1].
  • Cataract Formation: The medication may accelerate the development of cataracts (clouding of the eye’s natural lens)[8].
  • Endophthalmitis: A rare but serious infection inside the eye[2].
  • Retinal Detachment: Another rare but serious complication where the retina separates from the back of the eye[2].

Your eye doctor will monitor you closely for these potential side effects during treatment.

Ongoing Research

Researchers continue to study Fluocinolone Acetonide to better understand its long-term effects and explore its potential in treating other eye conditions. Some areas of ongoing research include:

  • Use in preventing vision loss due to radiation retinopathy[9].
  • Comparison with other treatments for various eye conditions[9].
  • Long-term safety and efficacy studies[1].
  • Use of advanced imaging techniques to monitor treatment response[10].

These ongoing studies aim to improve our understanding of how best to use Fluocinolone Acetonide to help patients with various eye conditions.

Aspect Details
Drug Name Fluocinolone Acetonide
Administration Method Intravitreal implants or inserts
Conditions Studied Non-infectious uveitis, Diabetic macular edema, Retinal vein occlusion, Age-related macular degeneration
Dosages Various, including 0.2 μg/day, 0.5 μg/day, 0.59 mg, and 2.1 mg implants
Primary Outcomes Changes in visual acuity, recurrence of uveitis, changes in macular thickness
Secondary Outcomes Intraocular pressure changes, need for additional treatments, quality of life measures
Safety Monitoring Intraocular pressure, cataract formation, endophthalmitis, retinal status
Study Designs Randomized, double-masked, controlled studies; observational studies
Follow-up Duration Varies by study, ranging from several months to 3 years

FAQ

  • What is Fluocinolone Acetonide and how is it used in eye treatments? Fluocinolone Acetonide is a corticosteroid medication used to treat inflammation in the eye. In these clinical trials, it is being studied as an intravitreal implant or insert, which means it's placed directly inside the eye to deliver the medication over an extended period.
  • What eye conditions are being studied with Fluocinolone Acetonide? The clinical trials are investigating Fluocinolone Acetonide for various eye conditions, including non-infectious uveitis affecting the posterior segment of the eye, diabetic macular edema, retinal vein occlusion, and age-related macular degeneration.
  • How is Fluocinolone Acetonide administered in these trials? Fluocinolone Acetonide is being administered as intravitreal implants or inserts. These are small devices that are placed inside the eye, either through injection in a clinic setting or through a surgical procedure, depending on the specific product being studied.
  • What are the potential benefits of using Fluocinolone Acetonide implants? The potential benefits include long-term control of inflammation, reduction in macular edema, improvement or stabilization of vision, and a decrease in the need for frequent eye injections or systemic medications.
  • What are some of the side effects being monitored in these trials? The trials are monitoring for side effects such as increased intraocular pressure (IOP), cataract formation or progression, and other potential complications like endophthalmitis (eye infection). The studies also assess the overall safety profile of the implants.

Ongoing Clinical Trials on Fluocinolone Acetonide

  • Study on the Safety and Effectiveness of Fluocinolone Acetonide Implant for Children Aged 6-17 with Recurrent Non-Infectious Uveitis in the Eye’s Posterior Segment

    Recruiting

    1 1 1 1
    Investigated drugs:
    Germany Spain

  • Study Comparing Fluocinolone Acetonide and Dexamethasone Implants for Patients with Resistant Diabetic Macular Edema

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia Finland +12

Glossary

  • Intravitreal: Refers to the space within the eye, specifically the area behind the lens and in front of the retina. Intravitreal treatments are administered directly into this space.
  • Uveitis: Inflammation of the uvea, the middle layer of the eye. It can affect the front, middle, or back of the eye and can cause vision problems if left untreated.
  • Macular Edema: Swelling or thickening of the macula, the central part of the retina responsible for sharp, detailed vision. It can occur due to various conditions like diabetes or retinal vein occlusion.
  • Retinal Vein Occlusion: A blockage of the small veins that carry blood away from the retina. This can lead to bleeding, swelling, and potential vision loss.
  • Intraocular Pressure (IOP): The fluid pressure inside the eye. Elevated IOP is a risk factor for glaucoma and is closely monitored in eye treatments.
  • Vitreous: The clear, gel-like substance that fills the space between the lens and the retina in the eye.
  • Fluorescein Angiography: An imaging technique used to examine blood flow in the retina and choroid, often used to diagnose and monitor various eye conditions.
  • Optical Coherence Tomography (OCT): A non-invasive imaging test that uses light waves to take cross-section pictures of the retina, allowing detailed examination of its layers.

References

  1. https://clinicaltrials.gov/study/NCT00456482
  2. https://clinicaltrials.gov/study/NCT01781936
  3. https://clinicaltrials.gov/study/NCT00490815
  4. https://clinicaltrials.gov/study/NCT01304706
  5. https://clinicaltrials.gov/study/NCT00407082
  6. https://clinicaltrials.gov/study/NCT00770770
  7. https://clinicaltrials.gov/study/NCT00695318
  8. https://clinicaltrials.gov/study/NCT00605423
  9. https://clinicaltrials.gov/study/NCT05844982
  10. https://clinicaltrials.gov/study/NCT04340505